# FRS2

## Overview
FRS2 (fibroblast growth factor receptor substrate 2) is a gene that encodes an adaptor protein involved in critical cellular signaling pathways. The FRS2 protein plays a pivotal role in mediating signal transduction from receptor tyrosine kinases (RTKs), particularly fibroblast growth factor receptors (FGFRs), to downstream signaling cascades such as the MAPK and PI3K/AKT pathways. These pathways are essential for regulating cellular processes including proliferation, differentiation, and survival (Zhou2009FGFreceptor; Ong2000FRS2). Structurally, FRS2 is characterized by an N-terminal myristoylation site, a phosphotyrosine-binding (PTB) domain, and multiple tyrosine phosphorylation sites, which facilitate its interactions with various signaling proteins (Zeng2014Structural; Ong2000FRS2). The gene is located on chromosome 12q13-15 and is frequently amplified in several cancers, highlighting its clinical significance as a potential therapeutic target (Zhang2013Amplification; Amoroso2019Genomic).

## Structure
FRS2 (fibroblast growth factor receptor substrate 2) is a protein characterized by several structural features that facilitate its role in signal transduction. The protein contains an N-terminal myristoylation site, which anchors it to the cell membrane (Ong2000FRS2). It possesses a phosphotyrosine-binding (PTB) domain, which is crucial for its interaction with receptor tyrosine kinases (RTKs) such as FGFR1 and TrkA. This domain can bind both phosphorylated and non-phosphorylated sequences, with a high degree of sequence similarity between the PTB domains of FRS2α and FRS2β isoforms (Zeng2014Structural; Ong2000FRS2).

The PTB domain of FRS2α has been structurally characterized, revealing a canonical fold with seven β-strands and one α-helix, forming two groups of anti-parallel β-sheets in an orthogonal arrangement (Zeng2014Structural). The C-terminus of FRS2 contains multiple tyrosine phosphorylation sites, which serve as binding sites for proteins like Grb2 and Shp2 upon phosphorylation (Ong2000FRS2). These phosphorylation events are critical for the recruitment of signaling complexes and the activation of downstream pathways such as the Ras/MAPK cascade (Ong2000FRS2).

FRS2 is subject to alternative splicing, resulting in different isoforms that may affect its function and interactions (Ong2000FRS2). The protein's structure and interactions highlight its role as a key adaptor in RTK signaling pathways.

## Function
FRS2 (fibroblast growth factor receptor substrate 2) is an adaptor protein that plays a crucial role in signal transduction pathways by linking fibroblast growth factor receptors (FGFRs) to downstream signaling cascades. It is primarily involved in the MAPK and PI3K/AKT pathways, which are essential for various cellular processes such as proliferation, differentiation, and survival (Zhou2009FGFreceptor; Ong2000FRS2).

FRS2 is anchored to the cell membrane and constitutively binds to FGFRs through its phosphotyrosine-binding (PTB) domain. Upon stimulation by fibroblast growth factors, FRS2 undergoes rapid tyrosine phosphorylation, creating docking sites for proteins like Grb2 and Shp2. This phosphorylation is critical for the activation of the Ras/MAPK signaling cascade, which regulates cell growth and differentiation (Zhou2009FGFreceptor; Ong2000FRS2).

In addition to its role in the MAPK pathway, FRS2 is involved in the recruitment and activation of PI3-kinase, influencing cell migration and survival. It also participates in crosstalk with other signaling pathways, such as the EGF pathway, integrating multiple external signals to modulate cellular responses (Zhou2009FGFreceptor). FRS2's function is essential for normal embryonic development and various physiological processes (Zhou2009FGFreceptor).

## Clinical Significance
The FRS2 gene, located on chromosome 12q13-15, is frequently amplified in various cancers, including high-grade liposarcomas, atypical lipomatous tumors (ALT), well-differentiated liposarcomas (WDL), dedifferentiated liposarcomas (DDL), and neuroblastoma. In high-grade liposarcomas, FRS2 amplification is often observed alongside CDK4 and MDM2, contributing to tumor growth through the activation of the FGFR/FRS2 signaling pathway (Zhang2013Amplification). This pathway's activation is implicated in the pathogenesis of these cancers, with phosphorylated FRS2 serving as a marker for activated FGFR signaling (Zhang2013Amplification).

In ALT/WDL and DDL, FRS2 amplification is consistent and may be linked to specific clinicopathological features, with a higher FRS2/CEP12 ratio observed in DDLs compared to ALT/WDLs (Jing2018Amplification). The gene's amplification is also associated with poor prognosis in neuroblastoma patients, where it is coamplified with CDK4 and MDM2, leading to worse overall survival in advanced stages (Amoroso2019Genomic).

FRS2's role as a key adaptor protein in the FGFR pathway suggests its potential as a therapeutic target, as inhibiting this pathway can suppress tumor growth (Zhang2013Amplification). The gene's amplification and overexpression highlight its significance in cancer development and progression.

## Interactions
FRS2 (fibroblast growth factor receptor substrate 2) is a key adaptor protein involved in various protein-protein interactions that facilitate signal transduction pathways. It interacts with fibroblast growth factor receptors (FGFRs) and nerve growth factor receptors (TrkA), playing a significant role in the MAPK/ERK signaling pathway. FRS2 binds directly and constitutively to FGFR1 through its phosphotyrosine-binding (PTB) domain, independent of receptor activation and tyrosine phosphorylation (Ong2000FRS2). 

Upon stimulation by nerve growth factor (NGF), FRS2 is tyrosine-phosphorylated and interacts with the TrkA receptor, competing with the Shc adapter protein for binding at the same phosphotyrosine residue (Ong2000FRS2; Meakin1999The). This interaction is crucial for recruiting intracellular signaling pathways and is dependent on receptor activation and phosphorylation (Ong2000FRS2).

FRS2 also interacts with several other proteins, including Grb2, Crk, and SHP-2, in a phosphorylation-dependent manner. These interactions facilitate the formation of complexes such as Grb2-Sos and Shp2-Grb2-Sos, which are essential for downstream signaling (Lim1999Association; Ong2000FRS2). Additionally, FRS2 can bind to the SH3 domain of Src constitutively, independent of NGF stimulation (Meakin1999The). These interactions highlight FRS2's role as a scaffold for multiple signaling proteins, influencing cellular processes such as differentiation and proliferation.


## References


[1. (Jing2018Amplification) Wenyi Jing, Ting Lan, Huijiao Chen, Zhang Zhang, Min Chen, Ran Peng, Xin He, and Hongying Zhang. Amplification of frs2 in atypical lipomatous tumour/well‐differentiated liposarcoma and de‐differentiated liposarcoma: a clinicopathological and genetic study of 146 cases. Histopathology, 72(7):1145–1155, March 2018. URL: http://dx.doi.org/10.1111/his.13473, doi:10.1111/his.13473. This article has 16 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1111/his.13473)

[2. (Meakin1999The) Susan O. Meakin, James I.S. MacDonald, Ela A. Gryz, Christopher J. Kubu, and Joseph M. Verdi. The signaling adapter frs-2 competes with shc for binding to the nerve growth factor receptor trka. Journal of Biological Chemistry, 274(14):9861–9870, April 1999. URL: http://dx.doi.org/10.1074/jbc.274.14.9861, doi:10.1074/jbc.274.14.9861. This article has 182 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1074/jbc.274.14.9861)

[3. (Lim1999Association) Yoon Pin Lim, Boon Chuan Low, Jormay Lim, Esther Sook Miin Wong, and Graeme R. Guy. Association of atypical protein kinase c isotypes with the docker protein frs2 in fibroblast growth factor signaling. Journal of Biological Chemistry, 274(27):19025–19034, July 1999. URL: http://dx.doi.org/10.1074/jbc.274.27.19025, doi:10.1074/jbc.274.27.19025. This article has 27 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1074/jbc.274.27.19025)

[4. (Zhang2013Amplification) Keqiang Zhang, Kevin Chu, Xiwei Wu, Hanlin Gao, Jinhui Wang, Yate-Ching Yuan, Sofia Loera, Kimberley Ho, Yafan Wang, Warren Chow, Frank Un, Peiguo Chu, and Yun Yen. Amplification of frs2 and activation of fgfr/frs2 signaling pathway in high-grade liposarcoma. Cancer Research, 73(4):1298–1307, February 2013. URL: http://dx.doi.org/10.1158/0008-5472.CAN-12-2086, doi:10.1158/0008-5472.can-12-2086. This article has 113 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1158/0008-5472.CAN-12-2086)

[5. (Zeng2014Structural) Lei Zeng, Miklos Kuti, Shiraz Mujtaba, and Ming‐Ming Zhou. Structural insights into frs2α ptb domain recognition by neurotrophin receptor trkb. Proteins: Structure, Function, and Bioinformatics, 82(7):1534–1541, June 2014. URL: http://dx.doi.org/10.1002/prot.24523, doi:10.1002/prot.24523. This article has 15 citations.](https://doi.org/10.1002/prot.24523)

[6. (Amoroso2019Genomic) Loredana Amoroso, Marzia Ognibene, Martina Morini, Massimo Conte, Andrea Di Cataldo, Annalisa Tondo, Paolo D’Angelo, Aurora Castellano, Alberto Garaventa, Vito A. Lasorsa, Marina Podestà, Mario Capasso, and Annalisa Pezzolo. Genomic coamplification of cdk4/mdm2/frs2 is associated with very poor prognosis and atypical clinical features in neuroblastoma patients. Genes, Chromosomes and Cancer, 59(5):277–285, December 2019. URL: http://dx.doi.org/10.1002/gcc.22827, doi:10.1002/gcc.22827. This article has 21 citations.](https://doi.org/10.1002/gcc.22827)

[7. (Ong2000FRS2) S. H. Ong, G. R. Guy, Y. R. Hadari, S. Laks, N. Gotoh, J. Schlessinger, and I. Lax. Frs2 proteins recruit intracellular signaling pathways by binding to diverse targets on fibroblast growth factor and nerve growth factor receptors. Molecular and Cellular Biology, 20(3):979–989, February 2000. URL: http://dx.doi.org/10.1128/mcb.20.3.979-989.2000, doi:10.1128/mcb.20.3.979-989.2000. This article has 434 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1128/mcb.20.3.979-989.2000)

[8. (Zhou2009FGFreceptor) Wenchao Zhou, Xiujing Feng, Yingjie Wu, Johannes Benge, Zhe Zhang, and Zhengjun Chen. Fgf-receptor substrate 2 functions as a molecular sensor integrating external regulatory signals into the fgf pathway. Cell Research, 19(10):1165–1177, August 2009. URL: http://dx.doi.org/10.1038/cr.2009.95, doi:10.1038/cr.2009.95. This article has 24 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1038/cr.2009.95)